Abstract: A system to assist in monitoring and improving services in hotels, motels and other lodging facilities. The system includes a plurality of fixed-location wireless devices that are situated throughout the facility and each service provider or asset to be monitored or tracked is provided with a cooperating mobile wireless device. The mobile devices may periodically transmit beacons that are received by the fixed location devices. The system may determine location based on evaluation of signal strength across a plurality of fixed devices. The system may include premapped calibration data on signal strength to assist in determining location. The location information may help to assess employee performance, to assist in improving performance and to provide improved services. The system may also interact with an application running on a hotel guest's electronic device to allow the system to track guest location. Guest location information can be used to provide improved guest services.

Abstract: A shear stud feeder for a stud welding gun may include a support frame having a first slide rail and a second slide rail longitudinally spaced apart from the first slide rail to form a slot therebetween. The shear stud feeder may also include a magazine removably engaged with the support frame. The magazine may be adapted to support a plurality of shear studs by the head of each shear stud in a manner in which the body of each shear stud hangs below a bottom of the magazine and wherein the magazine is adapted to dispense the plurality of shear studs to the slot. The shear stud feeder may include a feed mechanism disposed adjacent to either the first slide rail or the second slide rail and a gate assembly adjacent to a front end of each of the first slide rail and the second slide rail.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: A system to assist in monitoring and improving services in hotels, motels and other lodging facilities. The system includes a plurality of fixed-location wireless devices that are situated throughout the facility and each service provider or asset to be monitored or tracked is provided with a cooperating mobile wireless device. The mobile devices may periodically transmit beacons that are received by the fixed location devices. The system may determine location based on evaluation of signal strength across a plurality of fixed devices. The system may include premapped calibration data on signal strength to assist in determining location. The location information may help to assess employee performance, to assist in improving performance and to provide improved services. The system may also interact with an application running on a hotel guest's electronic device to allow the system to track guest location. Guest location information can be used to provide improved guest services.

Abstract: A control device for a first lighting load on a vehicle or trailer features an input connected to a lighting circuit through which a different second lighting load is operated, thus placing the controller in parallel relation with the lighting circuit, and a power output connected to the first lighting load on the vehicle or trailer. The controller is configured to detect from the input, a signal change sequence in the lighting circuit that comprises an initial high-to-low signal downstep, and a subsequent low-to-high signal upstep completed within a limited time window triggered by the initial high-to-low signal downstep. In response to detection of this signal change sequence, the controller energizes the first lighting load. If the second lighting load is the vehicle headlights, for example, a user can turn on the first lighting load by momentarily flipping the headlight switch off, and then quickly back on again.

Abstract: A system to assist in monitoring and improving services in hotels, motels and other lodging facilities. The system includes a plurality of fixed-location wireless devices that are situated throughout the facility and each service provider or asset to be monitored or tracked is provided with a cooperating mobile wireless device. The mobile devices may periodically transmit beacons that are received by the fixed location devices. The system may determine location based on evaluation of signal strength across a plurality of fixed devices. The system may include premapped calibration data on signal strength to assist in determining location. The location information may help to assess employee performance, to assist in improving performance and to provide improved services. The system may also interact with an application running on a hotel guest's electronic device to allow the system to track guest location. Guest location information can be used to provide improved guest services.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: A system to assist in monitoring and improving services in hotels, motels and other lodging facilities. The system includes a plurality of fixed-location wireless devices that are situated throughout the facility and each service provider or asset to be monitored or tracked is provided with a cooperating mobile wireless device. The mobile devices may periodically transmit beacons that are received by the fixed location devices. The system may determine location based on evaluation of signal strength across a plurality of fixed devices. The system may include premapped calibration data on signal strength to assist in determining location. The location information may help to assess employee performance, to assist in improving performance and to provide improved services. The system may also interact with an application running on a hotel guest's electronic device to allow the system to track guest location. Guest location information can be used to provide improved guest services.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: A system to assist in monitoring and improving services in hotels, motels and other lodging facilities. The system includes a plurality of fixed-location wireless devices that are situated throughout the facility and each service provider or asset to be monitored or tracked is provided with a cooperating mobile wireless device. The mobile devices may periodically transmit beacons that are received by the fixed location devices. The system may determine location based on evaluation of signal strength across a plurality of fixed devices. The system may include premapped calibration data on signal strength to assist in determining location. The location information may help to assess employee performance, to assist in improving performance and to provide improved services. The system may also interact with an application running on a hotel guest's electronic device to allow the system to track guest location. Guest location information can be used to provide improved guest services.

Abstract: The invention provides compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: The invention provides compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.

Abstract: The invention provides compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

Abstract: The invention provides compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

Abstract: Compounds which directly inhibit IRE-1? activity in vitro, prodrugs, and pharmaceutically acceptable salts there-of. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.